Insider trade

Pfizer's CEO Albert Bourla bought about $1M of company shares

Traded Aug 12, 2026 · Filed Aug 12, 2026

~$1M
Reported value · 38K sh @ $26.34: 429K
Holds after · shares reported: +6.9%
stock since the trade · S&P 500 -1.1%, $26.31 → $28.12 on Oct 1

Why it stands out

The boss of Pfizer spent $1M of their very own money to buy Pfizer shares. 2 other people at Pfizer bought some too, in the same month. Their pile of Pfizer shares grew by 10%.

Bought on the open market with their own money
Raised their holdings by 10%
3 different insiders at Pfizer bought within a month
Their first purchase in the data covering the past year

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 12, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 12, 2026

CEO$1M+Holdings +10%3 insiders bought in 30d

Context

Classification

open market purchase

Code P — open-market or private purchase

Absolute commitment

~$1,000,920

Shares × reported transaction price

Size band

$1M+

Ownership change

+9.7%

Purchase shares ÷ estimated pre-transaction holdings, from the filing

Rarity

Not enough history to judge

Confirmed open-market purchases by the same insider in the available history

Cluster activity

3 distinct insiders in 30 days

Distinct insiders at the same issuer with confirmed open-market purchases

Size vs CEO pay

This purchase equals about 3.6% of the CEO's reported total pay for fiscal 2025 ($27.6M)

Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-03-12. The proxy names Bourla as CEO for that year. A size comparison, not a judgement

Timing vs results

8 days after results of Aug 4, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $26.31 on Aug 12, 2026, 11% above its 52-week low and 8% below its high, after a 9% rise over the previous 30 trading days

52-week range $23.60 (Sep 25, 2025) to $28.55 (Apr 1, 2026), 55% of the way up, from 251 adjusted closes. 30 trading days earlier: $24.08 on Jun 30, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred